These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 449649)

  • 1. [Long-term management of arterial hypertension using a beta-adrenolytic agent in combination with a saluretic].
    Fryda-Kaurimsky Z; Krüger K; Krüger K
    Med Welt; 1979 Apr; 30(15):572-5. PubMed ID: 449649
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of the combination of Pindolol and clopamide in systemic arterial hypertension. A multicenter study].
    Zilenovski AM; Freire CA
    Arq Bras Cardiol; 1981 Sep; 37(3):219-24. PubMed ID: 7052028
    [No Abstract]   [Full Text] [Related]  

  • 3. [Long-term study of a combination of pindolol and clopamide (Viskaldix Sandoz)].
    Török E; Istvánffy M; Wagner M; Mahláry E; Podmaniczky M; Cseh K
    Lijec Vjesn; 1984; 106(11-12):501-8. PubMed ID: 6394937
    [No Abstract]   [Full Text] [Related]  

  • 4. [Potassium metabolism in combined administration of pindolol and clopamide in long-term treatment of hypertension (author's transl)].
    Faupel RP; Gotzen R
    Dtsch Med Wochenschr; 1978 Oct; 103(41):1602-5. PubMed ID: 100301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of the therapeutic efficacy of a fixed combination of beta blockader and diuretic, in the treatment of systemic arterial hypertension. A multicenter study].
    Zilenovski AM; Freire CA; Iverson MT
    Arq Bras Cardiol; 1984 Jun; 42(6):435-41. PubMed ID: 6393921
    [No Abstract]   [Full Text] [Related]  

  • 6. [Long term study (1 year) with a beta receptor blocker-diuretic combination in hypertension treatment].
    Gotzen R; Faupel RP; Hammerschmidt D
    Med Welt; 1981 Sep; 32(39):1450-2. PubMed ID: 7029197
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pindolol-clopamide combination in the treatment of arterial hypertension. Clinical study].
    Meilhac B; Bloch E; Zannier D; Metzger JP
    Therapie; 1983; 38(3):271-4. PubMed ID: 6612663
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of essential hypertension with pindolol and clopamide: problems arising from a combined beta blocker and diuretic therapy.
    Rosenfeld JB; Traub YM; Cohen L
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):786-97. PubMed ID: 4217245
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of hypertension with a fixed combination of pindolol and clopamide (VKB-105)].
    Sekso M; Vizner B; Benković K
    Lijec Vjesn; 1984; 106(11-12):512-4. PubMed ID: 6394939
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of pindolol, or a pindolol/clopamide combination preparation, on plasma lipid levels in essential hypertension. Hunter Hypertension Research Group.
    Med J Aust; 1989 Jun; 150(11):646, 648, 651-2. PubMed ID: 2657348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antihypertensive effectiveness of a guanfacine/clopamide combination].
    Wetzels E; Weidinger G
    MMW Munch Med Wochenschr; 1982 Oct; 124(40):871-4. PubMed ID: 6815503
    [No Abstract]   [Full Text] [Related]  

  • 12. A beta blocker-thiazide combination in the treatment of hypertension in diabetics.
    Chazan BI; Old JM; Venkataraman G; Snape J; Cameron EG
    Br J Clin Pract; 1981; 35(11-12):393-8. PubMed ID: 7030375
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of long-term treatment with a beta-receptor blocker, pindolol, combined with a diuretic agent, clopamide, on exercise performance in hypertension.
    Reiterer W
    Curr Med Res Opin; 1980; 6(8):552-8. PubMed ID: 7389386
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results of treatment of arterial hypertension using a pindolol preparation].
    Kinczkowska D; Idzińska M; Morawska M; Budniak Z; Weyssenhoff K; Zochowski RJ
    Pol Tyg Lek; 1986 Dec; 41(48):1524-7. PubMed ID: 3295811
    [No Abstract]   [Full Text] [Related]  

  • 15. [Quantitative data on the additive effect of a beta-receptor blockader and a saluretic in the therapy of hypertension. Interindividual-component comparison in a doble-blind study].
    Werning C; Hammerschmidt D; Kaiser Hj
    Med Welt; 1978 Oct; 29(40):1570-5. PubMed ID: 703579
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antihypertensive properties of a beta blocking agent, pindolol].
    Safar M; Weiss Y; Sobel A; Lagrue G; Milliez P
    Nouv Presse Med; 1973 Nov; 2(40):2685-8. PubMed ID: 4586561
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of hemodynamic changes in patients with primary arterial hypertension after treatment with a combination of pindolol and clopamide (Viskaldix)].
    Wyrzykowski B; Suchecka-Rachoń K
    Kardiol Pol; 1991; 34(5):286-91. PubMed ID: 1921111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term Viskaldix therapy in the treatment of hypertensive patients.
    Dudás M; Iványi J
    Ther Hung; 1985; 33(3):152-5. PubMed ID: 3842011
    [No Abstract]   [Full Text] [Related]  

  • 19. [Viskaldix in the treatment of arterial hypertension].
    Josipović V; Stefanović M; Kozarević D; Kozarević D; Knezević S
    Lijec Vjesn; 1984; 106(11-12):523-5. PubMed ID: 6394942
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of the treatment with pindolol and clopamide on left-ventricular systolic and diastolic time intervals in patients with moderate primary arterial hypertension].
    Gross-Sawicka E; Wyrzykowski B; Krupa-Wojciechowska B
    Pol Tyg Lek; 1988 Jul; 43(27):885-8. PubMed ID: 3072538
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.